Guanfacine used for treating ADHD in children and adolescents increases corneal aberrations at 6 months but does not affect the retina, choroid, refraction, or optic nerve.
Despite a long waitlist, the number of children served in the YES Waiver program has declined because of provider shortages.
ADHD has been associated with abnormal neuronal activity in various neuronal circuits, such as the dorsofrontostriatal, orbitofrontostriatal, and frontocerebellar circuits. Psychopharmacological ...
Improvements in ADHD impairments following a month of treatment with EndeavorRx were maintained for up to a month. No serious adverse events have been associated with EndeavorRx in any study to date.
Discussions explored causes of under-diagnosis, examined biases operating across referral, diagnosis and treatment, together with recommendations for resolving these matters. Results: Cultural and ...
The game-based digital therapeutic (DTx) has been filed for approval with Japan’s Ministry of Health, Labour, and Welfare (MHLW) as a prescription treatment for ADHD based on a clinical trial ...
Access to ADHD treatment can be a problem in the U.S., and this could prevent people from getting the help they need. Others may also be hesitant to accept an ADHD diagnosis and take medications that ...
The demand for ADHD diagnoses is on the rise in the Netherlands, with a noticeable increase among young people and more women ...
WP2: The variation in ADHD diagnosis and treatment. We will describe in detail the geographical variation in ADHD ... Eoin Killackey, Orygen & Centre for Youth Mental Health, University of Melbourne, ...
The clinical efficacy of atomoxetine in the treatment of ADHD has been evaluated in six published clinical trials of children and adolescents and two studies enrolling only adults. Clinical trial ...
Predatory online groups exploit teens’ need for belonging, grooming them into self-harm. Without real initiation rites, ...
The Microsoft founder discusses “Source Code,” the first in a planned three-volume autobiography.